ImageVerifierCode 换一换
格式:DOCX , 页数:4 ,大小:19.57KB ,
资源ID:15352279      下载积分:3 金币
快捷下载
登录下载
邮箱/手机:
温馨提示:
快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。 如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝    微信支付   
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【https://www.bdocx.com/down/15352279.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录   QQ登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(版ema《化学原料药生产起始物料的选择和论证要求思考》中英文对照2Word文件下载.docx)为本站会员(b****2)主动上传,冰豆网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知冰豆网(发送邮件至service@bdocx.com或直接QQ联系客服),我们立即给予删除!

版ema《化学原料药生产起始物料的选择和论证要求思考》中英文对照2Word文件下载.docx

1、Explanatory note 6: 注释6Scientific reasoning with appropriate justification, considering the whole synthetic approach and control strategy, and incorporating all the various principles outlined above, should be used in order to justify the selection of the starting materials. Often, applicants/manufa

2、cturers will select just a few criteria and use them to justify starting material selection, e.g.: “Compound X is a well-characterised isolated material of defined chemical properties and structure, and constitutes a significant structural fragment of the active substance. Therefore it is selected a

3、s a starting material as per ICH Q11.” This line of argumentation is not comprehensive and therefore not acceptable. Control strategy alone is not a sufficient justification of a starting material. Equally, a long synthetic process will not necessarily compensate for a poor control strategy.在论述起始物料的

4、选择时,要采用适当的科学原理进行论述,考虑整个合成方法和控制策略,结合上列所有各类原则。通常,申报人/生产商会选择少数几个标准,使用它们对起始物料的选择进行论述,例如,“化合物X特性清楚,被分离,具有清楚的化学特性和结构,成为原料药的重要结构片断,因此根据ICH Q11它被选择作为起始物料”。这样的论述不够全面,因此不会被接受。仅仅只有控制策略的话,是不足以作为起始物料的论证依据的。同样,合成路线很长并不能弥补很差的控制策略5.1.2 Selection of starting materials for semi-synthetic drug substances 半合成原料药的起始物料的选

5、择在本指南中,半合成原料药是指原料药结构是由一部分化学合成结构和生物来源结构(例如,发酵、植物原料提取)合并而成。在有些情况下,申报人可以从来源物料(微生物或植物原料)开始描述生产工艺。当然,如果可以证明在合成步骤中分离出的一个中间体符合上述合成原料药起始物料选择的原则,则所分离出的中间体也可以提议作为起始物料。申报人尤其应评估是否可能对所拟的起始物料进行特性分析,包括其杂质谱、发酵或植物原料和提取工艺对原料药的杂质谱是否有影响。要说明微生物和其它污染所带来的风险。Explanatory note 7: 注释7It is re-emphasised that a semi-synthetic

6、starting material should comply with the general principles for starting materials already discussed above and summarised in explanatory note 6. If the fermentation step or extraction step is considered to be critical following the definition in explanatory note 2, and considering the potential for

7、variability in fermentation process or extraction step, then it should be carried out under GMP.5.2 Submission of information for starting material or source material 起始物料或来源物料的资料提交申报人应识别所有拟定的起始物料或源物料,提交适当的质量标准。应论证所拟的合成和半合成原料药的起始物料。Explanatory note 8: 注释8Information on the manufacturers and supplier

8、s of starting materials should be provided, including name and address, and a scheme of the synthetic route used to manufacture them, showing all reagents, catalysts and solvents used. Without this information, the suitability of specifications cannot be adequately assessed.要提交起始物料生产商和供应商的资料,包括名称、地址

9、、生产所用合成路线图、标示所用的所有试剂、催化剂和溶剂。没有这些资料,就无法对质量标准的适用性进行适当评审。The specification for a starting material should address impurities and is expected to consider suitable limits for known, unknown impurities and total impurities and where appropriate, limits for solvents, reagents and catalysts used during synt

10、hesis of a starting material. The acceptance criteria should be established based on origin, fate and purge of impurities present in the starting material, and where appropriate, should be designed to detect isomeric or other impurities which are potentially reactive and which may be carried through

11、 to the active substance.起始物料的质量标准应包括杂质,应考虑对已知、未知杂质和总杂质制订适当的限度,适当时还要制订起始物料合成中所用的溶剂、试剂和催化剂的限度。应根据起始物料中出现杂质的来源、去向和清除情况建立可接受标准,适当时,应设计检测异构体和其它可能反应,并带入原料药的杂质。Analytical methods used should be validated. A tabulated summary of the results of the validation carried out should be provided if critical for t

12、he quality of the active substance However, it is not necessary to provide a validation report.所用的分析方法应进行验证。如果分析方法对于原料药的质量非常关键,则需要采用表格总结的方式提交验证结果。当然,并不需要提交验证报告。5.2.1 Justification of starting material selection for synthetic drug substances 合成原料药起始物料选择的论证The applicant should provide a justification

13、for how each proposed starting material is appropriate in light of the general principles for the selection of starting materials outlined above in Section 5.1.1. This can include information on:申报人应提交资料,根据5.1.1部分所列的起始物料选择通则,论述为什么各所拟起始物料是适当的。论述可以包括以下资料 The ability of analytical procedures to detect

14、impurities in the starting material 分析方法可以检测到起始物料中的杂质 The fate and purge of those impurities and their derivatives in subsequent processing steps 这些杂质及其在之后工艺步骤中的衍生物的去向和清除, How the proposed specification for each starting material will contribute to the control strategy 所拟的各起始物料的质量标准如何实现控制策略Explanato

15、ry note 9: 注释9The suitability of a starting material needs to be justified against the principles in section 5.1 as a whole, rather than against selected individual bullet points. Critical to satisfactory justification of a starting material, and for the assessment of the justification, is the description of the formation, fate and purge of impurities. The dossier must contain an appropriate discussion on known and unknown impurities including resi

copyright@ 2008-2022 冰豆网网站版权所有

经营许可证编号:鄂ICP备2022015515号-1